CLS is a medical technology company with headquarters in Lund, Sweden. We develop and sell tools for safe and precise treatment of diseased tissue by laser ablation. Today our products are primarily used for minimally invasive treatments of low to inter-mediate prostate cancer, brain tumors and epileptic foci.
Focal therapy means removing the cancer, while leaving the rest of the organ intact. An energy source is used to locally kill diseased tissue. This way as much normal function as possible is preserved, with minimal side effects and short recovery times.
At CLS we are developing and selling focal therapy systems based on laser that destroys the target tissue in a precise and controlled way.
Read about CLS’ exciting journey from 2006 until now, which started with Professor Karl-Göran Tranberg discovering that laser-mediated heat could both destroy cancer and activate the immune system.
Treating severe diseases as cancer in a precise and careful way is CLS’ driving force. Our exciting journey has started and we continuously add new skills and energy to our dynamic team.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
